EP0800531A4 - Neue rezeptor tyrosinkinase - Google Patents

Neue rezeptor tyrosinkinase

Info

Publication number
EP0800531A4
EP0800531A4 EP95943567A EP95943567A EP0800531A4 EP 0800531 A4 EP0800531 A4 EP 0800531A4 EP 95943567 A EP95943567 A EP 95943567A EP 95943567 A EP95943567 A EP 95943567A EP 0800531 A4 EP0800531 A4 EP 0800531A4
Authority
EP
European Patent Office
Prior art keywords
tyrosine kinase
kinase activity
new receptors
receptors
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95943567A
Other languages
English (en)
French (fr)
Other versions
EP0800531A2 (de
Inventor
Alastair Reith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ludwig Cancer Research
Original Assignee
Ludwig Cancer Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9420389A external-priority patent/GB9420389D0/en
Priority claimed from GBGB9510574.8A external-priority patent/GB9510574D0/en
Application filed by Ludwig Cancer Research filed Critical Ludwig Cancer Research
Publication of EP0800531A2 publication Critical patent/EP0800531A2/de
Publication of EP0800531A4 publication Critical patent/EP0800531A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4716—Muscle proteins, e.g. myosin, actin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP95943567A 1994-10-10 1995-10-10 Neue rezeptor tyrosinkinase Withdrawn EP0800531A4 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9420389A GB9420389D0 (en) 1994-10-10 1994-10-10 Novel receptor tyrosine kinase
GB9420389 1994-10-10
GBGB9510574.8A GB9510574D0 (en) 1995-05-24 1995-05-24 Novel receptor tyrosine kinases
GB9510574 1995-05-24
PCT/US1995/013490 WO1996011664A2 (en) 1994-10-10 1995-10-10 Nsk2 a muscle receptor tyrosine kinase

Publications (2)

Publication Number Publication Date
EP0800531A2 EP0800531A2 (de) 1997-10-15
EP0800531A4 true EP0800531A4 (de) 1999-09-22

Family

ID=26305770

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95943567A Withdrawn EP0800531A4 (de) 1994-10-10 1995-10-10 Neue rezeptor tyrosinkinase

Country Status (4)

Country Link
EP (1) EP0800531A4 (de)
JP (1) JP2002517166A (de)
AU (1) AU4500696A (de)
WO (1) WO1996011664A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5681714A (en) * 1992-07-30 1997-10-28 Mount Sinai Hospital Corporation Nucleic acid encoding tek receptor tyrosine kinase
US6028053A (en) * 1995-10-27 2000-02-22 Mount Sinai Hospital Corporation Peptide inhibitors of a phosphotyrosine-binding domain containing protein
EP0874639A4 (de) * 1995-10-27 1999-07-28 Mount Sinai Hospital Corp Peptid-inhibitoren eines proteins, das eine phosphotyrosin-bindedomäne umschliesst

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996002643A1 (en) * 1994-07-20 1996-02-01 Regeneron Pharmaceuticals, Inc. Denervated muscle kinase (dmk), a receptor of the tyrosine kinase super family
WO1996002644A1 (en) * 1994-07-20 1996-02-01 Genetics Institute, Inc. Mlk receptor tyrosine kinases

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996002643A1 (en) * 1994-07-20 1996-02-01 Regeneron Pharmaceuticals, Inc. Denervated muscle kinase (dmk), a receptor of the tyrosine kinase super family
WO1996002644A1 (en) * 1994-07-20 1996-02-01 Genetics Institute, Inc. Mlk receptor tyrosine kinases

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
See also references of WO9611664A3 *
VALENZUELA D.M. ET AL.: "Receptor tyrosine kinase specific for the skeletal muscle lineage: expression in embryonic muscle, at the neuromuscular junction, and after injury", NEURON, vol. 15, no. 3, September 1995 (1995-09-01), pages 573 - 584, XP000674260 *

Also Published As

Publication number Publication date
AU4500696A (en) 1996-05-06
WO1996011664A2 (en) 1996-04-25
WO1996011664A3 (en) 1996-07-04
JP2002517166A (ja) 2002-06-11
EP0800531A2 (de) 1997-10-15

Similar Documents

Publication Publication Date Title
ATE198329T1 (de) Chinazolin-derivate
ATE205483T1 (de) Chinazolinderivate
NO992336D0 (no) Raf-kinase-inhibitorer
ID24289A (id) Benzotiazol inhibitor-inhibitor protein terosin kinase
NO970501D0 (no) Substituerte kinazolinderivater
ID24951A (id) Komposist-komposit serat selulosa
NO982182D0 (no) Proteinkinase C-inhibitor
FR05C0030I2 (fr) Derives d'azahexane heterocycliques a activite antivirale
ATE248827T1 (de) (-)cis-6(s)-phenil-5(r)(4-(2-pyrrolidin-1-yl
FI961758A7 (fi) Kinatsoliinijohdannainen
IS5379A (is) Efnasambönd með taugafrumuvirkni
FI955661A7 (fi) Substituoidut beta-aryyli- ja beta-heteroaryyli-alfa-syanoakryyliamidi johdannaiset tyrosiinikinaasi-inhibiittoreina
EP0858456A4 (de) Triterpen-derivate mit immunosuppressiver aktivität
PT1020448E (pt) Aril-heterociclos com actividade herbicida
KR970004200U (ko) 샤워기헤드 지지대
DE69133436D1 (de) Protein-tyrosinkinase
FI971352L (fi) Sytoplasminen tyrosiinikinaasi
KR960038021U (ko) 버너헤드의 구조
KR960036126U (ko) 책상용 상판구조
LV11867A (lv) Mikrokristaliskas celulozes iegusanas panemiens
FI4159U1 (fi) Parvekkeen tuentarakenne
KR960028224U (ko) 목탁 받침구
ES1034582Y (es) Cilindro arte
KR960003838U (ko) 걸이판이 구비된 간이의자
FI971226L (fi) Reseptori-tyrosiinikinaasin (Tie) promottori

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19970422

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

A4 Supplementary search report drawn up and despatched

Effective date: 19990810

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

18W Application withdrawn

Withdrawal date: 19990823